Xarelto (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Xarelto drug offered from Janssen Pharmaceuticals, Inc.. This Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | rivaroxaban |
| SUBSTANCE NAME: | RIVAROXABAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-11-04 |
| END MARKETING DATE: | 0000-00-00 |
Xarelto HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xarelto from Janssen Pharmaceuticals, Inc. |
| LABELER NAME: | Janssen Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1) |
| START MARKETING DATE: | 2011-11-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50458-578_b4b04c7f-9e60-44a3-8987-a7cf0dd849fb |
| PRODUCT NDC: | 50458-578 |
| APPLICATION NUMBER: | NDA202439 |
Other RIVAROXABAN Pharmaceutical Manufacturers / Labelers:
